1 |
0.9% sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 4件: 6 , 14, 51, 53 💬 |
2 |
0.9% sodium chloride (normal saline) |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 1件: 6 💬 |
3 |
0.9% sodium chloride injection |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
168 1件: 168 💬 |
4 |
0.9% w/v isotonic sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
050 1件: 50 💬 |
5 |
0.9% w/v sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
6 |
Dexmedetomidine |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 12件: 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
7 |
Dexmedetomidine 1 |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
280 1件: 280 💬 |
8 |
Dexmedetomidine 2 |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
280 1件: 280 💬 |
9 |
Dexmedetomidine 3 |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
280 1件: 280 💬 |
10 |
Dexmedetomidine group |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
070 1件: 70 💬 |
11 |
Dexmedetomidine hydrochloride |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
070 1件: 70 💬 |
12 |
Dexmedetomidine hydrochloride infusion |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
13 |
Dexmedetomidine with ropivacaine |
Dexmedetomidine |
4件: D00514 D00514, D01205 D01205, D04048 D04048, D08490 D08490 💬 |
ADRA2A 8件: ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway |
070 1件: 70 💬 |
14 |
Fentanyl (low dose) + dexmedetomidine |
Dexmedetomidine |
4件: D00320 D00320, D00514 D00514, D01205 D01205, D01399 D01399 💬 |
ADRA2A 4件: ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 |
Estrogen signaling pathway 4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
215 1件: 215 💬 |
15 |
Isotonic sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
034 1件: 34 💬 |
16 |
Other: 0.9% sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
065 1件: 65 💬 |
17 |
Other: 0.9ml sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
271 1件: 271 💬 |
18 |
Other: sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
051 1件: 51 💬 |
19 |
Physiological serum (sodium chloride) |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
193 1件: 193 💬 |
20 |
Procedure: 9% sodium chloride (nacl) iv |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
078 1件: 78 💬 |
21 |
Scopolamine, atropine, edaravone and dexmedetomidine |
Atropine |
9件: D00113 D00113, D00138 D00138, D00514 D00514, D01077 D01077, D01205 D01205, D01552 D01552, D02069 D02069, D03011 D03011, D03814 D03814 💬 |
ADRA2A 8件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 1件: 2 💬 |
22 |
Sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
23 |
Sodium chloride (7%) |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
24 |
Sodium chloride 0,9% |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
25 |
Sodium chloride 0.9% |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
014 1件: 14 💬 |
26 |
Sodium chloride 6% |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
27 |
Sodium chloride 7% |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
28 |
Sodium chloride ph. eur. |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
29 |
Sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
011 3件: 11, 13, 228 💬 |
30 |
Sodium chloride solution 0.9% |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
060 3件: 60, 288, 299 💬 |
31 |
Sodium chloride solvent |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
228 1件: 228 💬 |
32 |
Sodium pyruvate in 0.9% sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
33 |
Solucion de cloruro de sodio sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
228 1件: 228 💬 |
34 |
Solvente cloruro de sodio sodium chloride solvent |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
228 1件: 228 💬 |